Citron Pharma Launches Generic Cymbalta Delayed Release Capsules

Citron Pharma LLC today announced that its New Jersey-based business has launched Duloxetine Delayed-Release Capsules USP in 20 mg, 30 mg and 60 mg strengths. Duloxetine Delayed-Release Capsules USP are the generic version of Eli Lilly's Cymbalta® delayed release capsules, and are indicated for the treatment of major depressive disorder, and generalized anxiety disorder, among other indications. Citron Pharma received final approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) it has exclusively licensed for this product and will begin shipping immediately. Commenting on the launch, Citron Pharma CEO Mr. Vimal Kavuru said, “I am pleased to announce our first big launch with Duloxetine Delayed-Release Capsules. We See full press release